Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Development of antiinflammatory/analgesic drug discontinued

Nov. 8, 1996

Progress on Scotia's rheumatoid arthritis treatment

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-1 receptor antagonists claimed by HMR/Affymax

Nov. 8, 1996

MMP inhibitors described by Procter & Gamble

Nov. 8, 1996

Sandoz reveals SLe(x)-mimetic compounds for treating inflammation

Nov. 8, 1996

Santen reports LTA4 hydrolase inhibitors

Nov. 8, 1996

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

Zenapax enters clinical trials for uveitis

Nov. 1, 1996

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Harbour Biomed closes busy year with $1B+ BMS deal
BioWorld
Harbour Biomed has added another collaboration to its end-of-year dealmaking, this time with Bristol Myers Squibb Co. (BMS) to develop multispecific antibodies....
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...